Wave Life Sciences WVE
NASDAQ WVE
$3.41 -0.07 (-2.02%)
As of: Nov 10, 2026 · 3:59 PM EST

Wave Life Sciences (WVE) Capital Leases (2015 - 2016)

Updated

Wave Life Sciences' Capital Leases was $16,000 in Q4 2016, down 79.5% from $78,000 a year earlier and down 48.4% from the prior quarter.

Analysis

Wave Life Sciences (WVE) Capital Leases (2015 - 2016) Analysis & Trends

From Q3 2015 onward, Wave Life Sciences has reported Capital Leases for 6 quarters.

  • In earlier years, Capital Leases was $78,000 in FY2015.
  • Per Business Quant data, WVE's Capital Leases in the three quarters before Q4 2016 was $31,000 (Q3 2016), $47,000 (Q2 2016) and $62,000 (Q1 2016).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn
10 Wave Life Sciences 715.80 Mn -1.23 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2016 16,000.00
Sep 30, 2016 31,000.00
Jun 30, 2016 47,000.00
Mar 31, 2016 62,000.00
Dec 31, 2015 78,000.00
Sep 30, 2015 94,000.00
API Access

Wave Life Sciences Capital Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-leases&ticker=WVE&period=max&api_key=YOUR_API_KEY